The human placenta is hemomonochorial, meaning that the maternal and fetal circulations are separated by a single layer of polarized epithelium called the syncytiotrophoblast, which is in direct contact with maternal blood. Transport proteins located in the microvillous and basal membranes of the syncytiotrophoblast are the principal mechanism for transfer from maternal blood to fetal blood. Knowledge of the function and regulation of syncytiotrophoblast amino acid transporters is of great importance in understanding the mechanism of placental transport and potentially improving fetal and newborn outcomes. The development of methods for the isolation of microvillous and basal membrane vesicles from human placenta over the past two decades has contributed greatly to this understanding. Now a primary cultured trophoblast model is available to study amino acid transport and regulation as the cells differentiate. The types of amino acid transporters and their distribution between the syncytiotrophoblast microvillous and basal membranes are somewhat unique compared with other polarized epithelia. These differences may reflect the unusual circumstance of this epithelium that is exposed to blood on both sides. The current state of knowledge as to the types of transport systems present in syncytiotrophoblast, their regulation, and the effects of maternal consumption of drugs on transport are discussed. syncytiotrop epithelium hoblast; microvillous membrane; basal membrane; polarized THE PLACENTA IS A specialized organ of fetal origin that performs numerous functions critical to normal growth and development of the fetus (24). The nature and importance of each function change with the intrauterine development of the fetus. The placental function of nutrient. transport from maternal blood to the fetal circulation is important throughout pregnancy and particularly in the last trimester as fetal size increases rapidly. Amino acids are an essential nutrient class, since they provide the building blocks for protein synthesis for the rapidly growing fetus. Normal fetal growth and development depend on a continuous supply of amino acids from maternal blood, involving uptake and transfer across the syncytiotrophoblast (87). The maternal and fetal circulations in the human are separated by a polarized epithelium known as the syncytiotrophoblast (Fig. 1) . Although resembling other epithelia including that of intestine, placental epithelium is a true syncytium, lacking lateral cell membranes. Undifferentiated stem cells (cellular trophoblast or cytotrophoblast) underlying this epithelium give rise to it by fusion (24). The apical membrane of the syncytiotrophoblast is in direct contact with maternal blood (hemochorial) and is composed of a microvillous structure resembling morphologically the apical membrane of the enterocyte. The basal membrane faces the fetal circulation and lacks the high degree of organization of the apical membrane. The trophoblast layer is the most metabolically active tissue of the placenta, even though it comprises only 13% of placental weight (88). The syncytiotrophoblast is the anatomic portion of the human placenta that mediates the exchange of nutrients and waste products between maternal and fetal circulations.
TRANSPLACENTAL PATHWAYS
Pathways of transsyncytial flux may be divided into either transcellular or paracellular mechanisms. Transcellular mechanisms may include simple diffusion down a concentration gradient or transfer by specific membrane-bound transport proteins (usually described as transport systems). The primary mechanism for the movement of amino acids from mother to fetus is thought to be a result of the functioning of specific amino acid transporters located in the microvillous and basal membranes of the syncytiotrophoblast (i.e., mediated transport). Maintenance of electrochemical gradients of sodium, potassium, chloride, and other ions provides the driving force for the operation of many of these transporters, whereas others operate by exchange mechanisms.
The paracellular pathway in the human placenta may represent sparsely distributed but relatively wide pores that transverse the syncytiotrophoblast (124, 125) . Transepithelial pores that potentially represent the morphological structure responsible for paracellular transport have been described in the hemomonochorial placenta of the degu (Octodon degus) and of humans (33, 66) . Paracellular transport can occur by diffusion from areas of higher concentration to areas of lower concentration or by bulk volume flow (126). Paracellular pathways predominate for transplacental flux of the inert hydrophilic solutes, mannitol, Cr-EDTA, and inulin (126). It is likely that paracellular pathways account for a negligible proportion of flux by small molecules in relatively low plasma concentrations such as amino acids.
The hypothesis that specific transport proteins in the two membranes of the syncytiotrophoblast are primarily responsible for the maternal-to-fetal transfer of amino acids is based partially on the fact that most amino acids are in higher concentration in fetal blood compared with maternal blood and in even higher concentrations in the placenta (23, 25, 77, 128, 133) . Therefore the transepithelial flux of most amino acids is against a concentration gradient that would necessitate a concentrative mechanism of transfer rather than simple diffusion. As an example, the mean fetal plasma lysine concentration for the five published studies (23, 25, 77, 128, 133) was threefold higher than the maternal plasma lysine concentration (92). For alanine, the concentration in fetal blood has been estimated to be twice that in maternal blood. Syncytial alanine concentration is sevenfold higher compared with maternal blood (92). There are a few exceptions, like glutamate and aspartate, which are found in roughly equal concentrations in each circulation (92).
TECHNIQUES TO STUDY PLACENTAL TRANSPORT
As the understanding of placental amino acid transport processes has grown, it has become apparent that, for the most part, the transporters present are not unique to the placenta but are types common to other cells and tissues. The distribution of these transporters between the apical and basal membranes of the syncytiotrophoblast may be different from other epithelia, and the role these transporters play in placental function is unique. Knowledge of these processes has come with the development of in vitro techniques to study the placental villous structure and specifically the two plasma membranes of the syncytiotrophoblast.
Placental amino acid transport has been investigated using villous fragments or slices (35, (113) (114) (115) , perfused placental cotyledon (48, (105) (106) (107) (108) , isolated plasma membrane vesicles from the microvillous (43, 58, 82, 85, 100) and basal membranes (40, 49, 50, 70, 71) , and primary cultured trophoblast cells (42, 60) as well as choriocarcinoma cell lines (42, 73, 84, 97) . Chronically catheterized sheep have proved to be a very important model for whole animal studies (45, 51, 74, 80, 85, 86) . It should be noted that the sheep placenta is a cotyledonary epitheliochorial (the trophoblast is not in direct contact with maternal blood) type placenta, whereas the human placenta is discoidal and hemomonochorial (meaning the tropho-Cl323 blast is in direct contact with maternal blood) (63). Several studies have been published using the perfused guinea pig placenta model (31, 131, 134) . Although the guinea pig placenta does not resemble the human placenta, it is similar, in that they are both of the hemochorial type (63). The study of placental transport necessitates the use of different models, and they have all contributed to our understanding of placental amino acid transport.
Investigators should consider species differences in placental structure and morphology as well as the fact that length of gestation, fetal growth rates, and fetal composition vary among species (6).
A significant achievement in the development of appropriate placental models was the isolation of relatively pure membrane vesicles from the syncytiotrophoblast microvillous (10, 117, 119) The neutral amino acid transport systems identified in the placental syncytiotrophoblast are common to many cell types. In this respect, the syncytiotrophoblast differs from intestine and kidney, which possess specialized epithelial transport systems (122). The known syncytial amino acid transporters can be found listed in Table 1 , according to the nomenclature originally developed by Christiansen.
Throughout this article the convention of designating sodium-dependent transporters with upper case letters and sodium-independent transporters by lower case letters is followed.
There are at least two sodium-dependent and two sodium-independent neutral amino acid systems found in the microvillous membrane. These are the sodiumdependent system A and system N and the sodiumindependent system 1 (formerly referred to as system L) (58). A set on sodium-independent system, which pred fers alanine, has also been proposed but is not well characterized (58). The A system resembles that found in other cell types, in that it has broad substrate specificity and is sensitive to N-methylated amino acids (58) such as a-(methylamino)isobutyric acid (MeAIB), which is considered to be a specific system A analogue. System N transports histidine and glutamine and is insensitive to methylated amino acids (62). System N is sodium dependent, electrogenic, and transstimulated. The sodium-independent system 1 was identified by its sensitivity to the amino acid analogue 2-amino-2-norbornane carboxylic acid and by its high affinity (apparent Michaelis constant 20 PM) for leucine uptake (58) . The microvillous membrane apparently lacks system ASC (42, 58, 71) or system t for tyrosine uptake (43,72). Sodium-dependent cysteine transport (i.e., suggestive of ASC transport) was reported in an investigation of the importance of storage conditions on the results of amino acid transport studies with placental microvillous membrane vesicles. Furesz et al. (42) did not observe ASC system transport in freshly prepared microvillous membrane vesicles as measured by MeAIB-resistant sodiumdependent alanine uptake. In the same report, measurable ASC activity was lost from cultured trophoblast cells and BeWo cells after differentiation and syncytial formation (42). These data suggest that ASC system activity decreases with syncytial formation and is consistent with the absence of the ASC system from the microvillous membrane. A portion of glycine uptake by microvillous membranes is MeAIB resistant, which suggests some non-system A uptake that perhaps represents system GLY activity (29).
The basal membrane of the syncytiotrophoblast possesses system A and system 1 transporters and, in addition, the sodium-dependent system ASC (50). System ASC is characterized by insensitivity to the analogue MeAIB and has somewhat narrower substrate specificity compared with system A. Alanine, serine, and cysteine are preferred substrates and thus give this system its name. There has been a suggestion but not confirmation that the basal membrane also possesses the sodium-independent system t for tyrosine transport (71).
ANIONIC AMINO ACIDS
Placental transport of anionic amino acids is unique because, unlike other amino acids, glutamate and aspartate are not transferred across the placenta (76, 105, 121). Net uptake of glutamate from the fetal circulation has been observed in some studies (51, 76, 81) . The ovine fetal liver is a net producer of glutamate (81). The placental tissue concentration of glutamate is orders of magnitude higher than concentrations in either the maternal or fetal circulation (92). Blood concentrations are roughly equal on both sides of the syncytiotrophoblast. The elevation of glutamate concentration within the placenta is accomplished by sodium-dependent potassium-coupled transporters located in the microvillous and basal membranes (49, 53, SS) . In functional studies, this transporter has been identified as the fairly ubiquitous Xio system (49,85). A distinguishing characteristic of the Xio system is that it is stereoselective for the stereoisomers of glutamate but does not discriminate between L-and D-aspartate. The normal orientation of sodium and potassium gradients in the syncytiotrophoblast of the placenta should drive concentrative uptake of anionic amino acids into the placenta. There the amino acids would be disposed of via metabolism, since an effective means of egress has not been found. Recent studies indicate an extremely high glutamate clearance rate from the fetal circulation, which is the result of glutamate disposal via oxidation to COZ (87). The main route of glutamate metabolism in human placental trophoblast also seems to be oxidation to COZ (13). The unique placental handling of glutamate may offer the developing fetal brain a protective mechanism from a potential neurotoxin. Consistent with this hypothesis is the recent observation in my laboratory that the human placental trophoblast expresses both of the brain type sodium-dependent glutamate transporters. In addition, glutamate oxidation may provide an important energy source to the placenta (13, 87) or provide a source of NADPH for placental lipid synthesis (86). The full-term placenta is an active producer of fatty acids and steroid hormones but has a low level of pentose phosphate pathway activity (83). Oxidation of glutamate via glutamate dehydrogenase (83) could provide the needed NADPH for fatty acid and cholesterol sysnthesis.
The cationic amino acids, like most of the neutral amino acids, are concentrated in the fetal circulation relative to concentrations in maternal circulation. Several types of cationic transporters seem to be present in the two membranes of the syncytiotrophoblast.
The most widely known is system y+, which is found in many cell types and in both membranes of the syncytiotrophoblast (34, 40, 41) . This transporter is sodium independent, has a relatively low affinity and high capacity, and is specific for cationic amino acids, with the exception that lysine uptake can be inhibited by certain neutral amino acids in the presence of sodium (40). Recent work in this laboratory suggests that the y+ systems of the placental microvillous and basal membranes may differ functionally. Lysine uptake by system y+ in the basal membrane is completely inhibited by neutral amino acids, including leucine, in the presence of sodium, whereas lysine uptake in the microvillous membrane is partially inhibited by neutral amino acids other than leucine (41). Thus there may be different subtypes of system y+ in the syncytiotrophoblast.
Given its higher maximum velocity compared with other cationic amino acid transporters, the y+ system has usually been assigned the function of the major cationic amino acid transporter in the placenta.
Other cationic transporters are present in both syncytial membranes. A high-affinity low-capacity system has been described in the basal membrane that has initially been ascribed to system b"T+ (40). The boy+ system was originally characterized in mouse blastocytes, is distinguished by a higher lysine affinity and lower capacity than system y+, and is inhibited by leucine in the absence of sodium (40, 130) . A second cationic system has been described in microvillous membranes and given the name y+L . This transporter was originally described in human erythrocytes (27) and subsequently by the same laboratory in the human placental microvillous membrane (34). Smith and co-workers (41) have been able to discriminate two systems in the microvillous membrane kinetically and by inhibition of system y+ with N-ethylmaleimide (NEM). The high-affinity system (which may be y+L) is temperature sensitive, with activity observable only at temperatures > 25°C (41). The system y+L as described by Deves et al. (27) has a much higher affinity for lysine and neutral amino acids than system y+. In addition, the y+L system is insensitive to treatment with NEM (26) and less sensitive to changes in membrane potential (34). These investigators (34) have hypothesized that the difference in sensitivity to membrane potential may play an important role in transepithelial flux of lysine (34). The maternal-to-fetal transfer of cationic amino acids in the human placenta is a complex process involving multiple transport systems whose identities are still an area of controversy.
Eleno et al. (34) report that a broad-spectrum transporter accounts for > 90% of lysine uptake in the basal membrane. These authors also question the interpretation that the high-affinity system reported earlier in the basal membrane (40) Taurine is also concentrated in the fetal blood and is in the highest concentration of any amino acid in placental tissue (92). Placental transfer has an obligatory role in supplying this important amino acid to meet fetal demands. Taurine is taken up at the microvillous membrane by a P-amino acid-specific transporter (61, 73, 82). The transporter is sodium and chloride dependent and is energized by gradients of these ions (82), and uptake is selectively impaired by cyclosporin A in a placental cell line (JAR) (97). Recently, the microvillous taurine transporter has been solubilized and reconstituted in proteoliposomes in functional form (95). This same group has cloned the transporter from a human placental cDNA library and used in situ hybridization to localize the 6.9-kilobase transcript to human chromosome 3 p24-p26 (98). The mechanism of transfer across the basal membrane is unknown. There is some evidence for channel-mediated taurine efflux from villous fragments Regulation of amino acid transepithelial flux has great potential importance to normal fetal growth and development, since the placental syncytiotrophoblast fulfills an obligatory role in providing amino acids to the developing fetus. Amino acid transport regulation occurs at several levels, and clearly the transport proteins in the two membranes must work in concert to bring about the concentration of amino acids in the fetal blood. The polarization of the two membrane domains with respect to transport proteins most likely accounts for a share of this coordination. For example, sodium-dependent transporters in the microvillous membrane can drive the uptake of neutral amino acids against a concentration gradient and thereby raise intracellular concentrations above that in fetal blood. Transport to the fetal circulation could then occur "downhill" by diffusion or exchange type mechanisms.
The actual situation in the placenta is more complicated, since the sodium-dependent A system is found in both the microvillous and basal membranes and system ASC is found only in the basal membrane.
The sodium-independent system 1 is located in both membranes. Cultured trophoblast uptake of cx-aminoisobutyrate (AIB) is stimulated by insulin, insulin-like growth factor I (IGF-I), and epiderma1 growth factor (EGF) (9,60). Bloxam et al. (9) used a two-sided culture technique so that the apical and basal surfaces were reportedly treated independently. These authors did not provide evidence as to the quality of their preparation in terms of maintaining two separate aqueous phases, and therefore it is difficult to judge whether the hormonal treatments were limited to a specific membrane as stated. Nevertheless, they report that EGF or IGF-I on the apical side reduced the rate of unidirectional (apical-to-basal) transfer and increased cellular retention. EGF on the basal side increased AIB flux in both directions, whereas IGF-I induced an increased flux into the basal media (9). AIB transport is potentially upregulated by IGF-II, dibutyryl adenosine 3',5'-cyclic monophosphate, and phorbol esters, and the insulin and IGF-I effects can be abolished by ethanol exposure (P. Karl, personal communication).
The sodium-independent systems and system ASC do not seem to be regulated by any of the above hormonal factors. Much work needs to be done to understand the regulation of placental amino acid transport at the cellular level and its role in transsyncytial flux.
MOLECULAR BIOLOGY OF AMINO ACID TRANSPORTERS
Recently, a number of amino acid transporters have been cloned in various mammalian tissues. With the exception of the taurine transporter (98), none have been cloned directly from placenta, although many are transporters that are found in the placenta. Two laboratories have independently cloned an ASC-like transporter based on its belonging to the same gene family as the previously cloned glutamate transporter (4, 109). Transporter message was found in placenta by both laboratories but at much lower levels than in brain, skeletal muscle, and pancreas. The identity of this transporter was investigated by expression in HeLa cells or expression in Xenopus oocytes. Both laboratories observed uptake of neutral amino acids, which was insensitive to the A system substrate MeAIB. However, more extensive characterization in HeLa cells revealed certain discrepancies between the cloned activity and known ASC system characteristics (i.e., a lack of mutual inhibition between serine and cysteine and a lack of transstimulation) (109). As more transport proteins are cloned, a major focus will be the characterization of these proteins with respect to function and comparison with the classically defined transport systems in the placenta and other organs.
System A is located in both the microvillous and basal membranes of the syncytiotrophoblast. A putative clone of system A (subsequently, doubts have been raised as to whether this is system A) from a kidney cell line has been reported (68). The authors concluded that this transporter that they designated SAATl is closely related to the sodium-glucose transporter (SGLUT-1).
As mentioned previously, the sodium-dependent glutamate transporter has been cloned. Two separate transporters have been cloned from the brain (93, 123) and a third from rabbit small intestine (59). In collaboration with Danbolt's laboratory, we have obtained preliminary evidence that antibodies to at least two of these transporters (the brain type) react with microvillous and basal membrane vesicles from human placenta (A. J. Moe, N. C. Danbolt, M. Landt, J. Storm-Mathisen, and C. H. Smith, unpublished observations). We have also established the presence of message for a transporter similar to the human brain (110) and rat brain transporter (123) by reverse transcriptase-polymerase chain reaction from trophoblast total RNA. The presence of a GLT-l-like transporter was established by screening a placental cDNA library with probes to the rat brain transporter (N. C. Danbolt, unpublished observations).
Several cationic amino acid transporters have recently been cloned from the tissues of various species (3, 22, 65) . These transporters apparently represent subtypes of system y+, but functional differences between the subtypes have yet to be reported. As already described in this review, our laboratory has reported on a functional difference between system y+ in the microvillous and basal membranes of the syncytiotrophoblast. Perhaps these differences between membranes may correlate with the molecular biology of cationic amino acid transporters. The p-amino acid transporter for taurine uptake has been cloned from rat brain (1 IS), thyroid cells (57), and a kidney cell line (127).
One of the difficulties that has been encountered with attempts to clone mammalian amino acid transporters has been the isolation of transporter activators rather than the transporters themselves (129). Many of the transporters of interest are endogenous to the expression systems (the most common beingxenopus oocytes), and it is difficult to rule out stimulation of an endogenous transporter in these experiments (129). It is clear from the current state of knowledge that many potential variants exist for the classical systems. The rapid pace of cloning and increased knowledge about the structure of these transport proteins is resulting in a major rethinking about the number and categorization of transport systems. Through cloning it may finally be possible to study the functional characteristics and regulation of individual amino acid transport proteins rather than a collection of different transporters.
INTRAUTERINE GROWTH RETARDATION AND AMINO ACID TRANSPORT
Impairment of fetal/neonatal growth and development results in intrauterine growth retardation or small-for-gestational age (SGA) babies (55). This condition can result from multiple causes, including many that are related to placental function (56, 90). Placental amino acid transport is of potential importance, since the developing fetus is totally dependent on the supply of amino acids from maternal blood for protein synthesis for accumulation of fetal mass. The umbilical venoarterial concentration differences of most essential amino acids is lower for intrauterine growth-retarded fetuses (15). The cord blood of growth-retarded neonates and fetuses also shows an increase in the glycine-to-valine ratio (15, 78) . Recently, it has been reported that system A transport is defective in microvillous membrane vesicles isolated from syncytiotrophoblasts of placentas of SGA babies (80). This is the first report linking a defect in a specific transport system of the syncytiotrophoblast to intrauterine growth retardation (80). It has now been established that factors that disrupt or inhibit the supply of amino acids across the placenta can lead to SGA babies (28).
Several conditions, including the ingestion of drugs by the pregnant woman, can cause decreased amino acid transport by the placenta and thus a decreased supply of amino acids to the fetus. Maternal ethanol consumption by pregnant rats caused a 30-40% reduction in valine uptake by placental villous fragments (47) and reductions of a similar magnitude when measured in vivo in the rat (91). Chronic ethanol consumption 30 days before and throughout gestation reduced placental valine uptake by 44% (47). Both short-and long-term ethanol exposure decreased fetal valine uptake (91). Other studies have found an effect of ethanol administration on AIB uptake in rodent placenta (39, 76) . Amino acid transport in the human and nonhuman primate placentas has proven to be relatively resistant to acute ethanol treatment (36, 38, 39, 103) . Chronic alcohol administration has depressed uptake of some amino acids in nonhuman primates (37).
Another factor that depresses fetal growth and is often found in conjunction with ethanol is tobacco smoke (38). Use of ethanol concurrent with tobacco smoking may be more harmful then either substance used independently (38). Babies born to mothers who smoke are on average 200 g lighter than those born to nonsmokers (46, 90, 132) . One possible cause of this lower birth weight is depressed amino acid transport across the placenta (101). Smoking increases nicotine concentrations in placenta, amniotic fluid, and fetal serum above concentrations found in maternal serum (79). Uptake of amino acids by isolated human placental villi is reduced by nicotine and several components of tobacco smoke (5, 99, 101, 102) . The mechanism of nicotineor ethanol-induced depression of placental amino acid uptake is still unknown. Studies using membrane vesicles have failed to show a direct effect of nicotine (104) or ethanol (103) on amino acid transporters.
Another major problem today is the ingestion of cocaine by pregnant women. Cocaine use can lead to numerous neonatal complications, with intrauterine growth retardation among them (112). Cocaine is known to inhibit placental uptake of amino acids (5) and binds to a high-affinity binding protein in human placenta (2, 30). Recent studies using membrane vesicles suggest a potential direct effect of cocaine on amino acid transport (30). The exact mechanism of this inhibition is unknown but seems to be limited to sodium-dependent transport systems (30).
Maternal diabetes and preeclampsia are complications of pregnancy that can also lead to alterations in placental amino acid transport and serious perinatal implications. A large or macrosomic fetus can' result from excessive intrauterine growth, which is a frequent outcome of diabetes mellitus-complicated pregnancies (7). Sodium-dependent MeAIB uptake was reduced 49% in microvillous membrane vesicles isolated from placentas of diabetic pregnancies resulting in macrosomic babies (74). As with an early report from another laboratory (28), these authors failed to demonstrate an effect of diabetic pregnancy without macrosomia on MeAIB uptake (74). Intuitively, a lower system A transport activity associated with macrosomia seems surprising but is consistent with results from the rat where streptozototin-induced diabetes resulted in lower fetal plasma amino acid concentrations (1).
ASYMMETRICAL FLUX OF AMINO ACIDS
The cellular basis for the asymmetrical maternal-tofetal transfer of amino acids across the placenta has yet to be established. Tran .sepithelial amino acid flux across the intestine has been explained by ion-driven concentrative uptake at the microvillous membrane and diffusion across the basolateral membrane (122). The same pump/ leak mechanism has been used to explain asymmetrical flux across the syncytiotrophoblast (116). As mentioned previously, a weakness of this theory is that it does not allow for fetal regulation of placental transport or the presence of sodium-dependent transporters in the basal membrane. In addition, there are alternative explanations for the possible role of the relatively high syncytial amino acid concentrations (92) in cellular functions other than transsyncytial flux. The nonprotein amino acid taurine is the amino acid fou nd in the highest concentration (10.4 mM) in the placenta (92). In many cell types, taurine plays a role in maintaining cell volume (52), and Shennan et al. (111) have provided eviden .ce that taurine may Play an osmoregulatory role in the placenta. The amino acid next highest in concentration in the placenta is glutamate (92), which we know is oxidized by the placenta (13,86) and is not transferred to the fetus. A recent report has also implicated amino acid-induced hyperosmolarity in activation of maternalto-fetal Cl-transfer (8).
Maternal-to-fetal transfer of amino acids requires movement across two membrane barriers. As discussed in this review, these membranes contain specific transport proteins for the translocation of all important amino acids and some small peptides. Because of this, the transport paradigm has always included the specific transport systems, even though it has not been possible to explain how the operation of these systems results in maternal-to-fetal transfer.
Some of the key aspects of maternal-to-fetal transfer that have received less attention and perhaps play significant roles in this process include intrasyncytial factors such as amino acid metabolism and membrane efflux pathways. Placental amino acid metabolism has received little attention (especially in humans), yet is known to impact placental handling of amino acids (13, 14, 85, 86) . Differential efflux across the microvillous and basal membranes may play an important role in maternal-to-fetal transfer (32). Uptake from the blood across each membrane could be roughly equivalent, provided that efflux across th .e basal membrane was more rapid relative to the microvillous membrane. Differential rates of efflux for the two membranes could very well be determined by the distribution of specific transporters in the two membranes. With our present ability to differentiate between transporter subtypes and to identify and characterize specific transport pro-teins, we hopefully will be able to understand the mechanisms responsible for asymmetric amino acid flux across the placental syncytiotrophoblast.
A great deal is yet to be learned about placental amino acid transporter structure, function, and regulation as well as the interrelationship of drugs and other substances.
The application of molecular biology techniques, along with the development of improved cell culture models, suggests the possibility of major advances in this important area of investigation. 
